Companies / Co-Diagnostics, Inc.

Co-Diagnostics, Inc.

Nasdaq: CODXCIK 1692415SALT LAKE CITY, UT

Financials · FY2025

Revenue$622.5K
Net income$-46.90M
Total debt$1.91M
Cash$3.65M
Diluted EPS$-35.25
Shares outstanding3.6M

Ownership

3.6M shares outstanding · as of May 12, 2026
0.30%Insiders
Ownership
Insiders0.30%10,751
Institutions0.46%16,722
Public float99.24%3,574,992

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Serbin Richard SDirector
0.30%10,751

Institutional holders 3

View all →
HolderValue% of shares
State Street Corporation$45.9K0.41%
SBI Securities Co., Ltd.$2360.04%
Heritage Wealth Advisors$890.01%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 23, 2026Serbin Richard S
Director
GrantCommon Stock$0+2K
+18.72%
10,751
0.30% of shares
low
May 23, 2026Serbin Richard S
Director
ExerciseRestricted Stock Unit—-2K
-29.76%
4,000
0.11% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Ayrton Capital LLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CODXCommon StockEquity189763204BBG004HTR2D1